Publikationen

Auswahl:

Aktuelles:

Originalarbeiten (Auswahl)

Meyer FJ, Borst MM, Zugck C, Kirschke A, Schellberg D, Kübler W, Haass M(2001) Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation 103: 2153-2158

Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, Strasser RH (2002) Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 39: 2019-2025

Jünger J, Schellberg D, Krämer S, Haunstetter A, Zugck C, Herzog W, Haass M (2002) Health related quality of life in congestive heart failure: comparison to other chronic diseases and relationship to functional parameters. Heart 87: 235-241

Kell R, Haunstetter A, Dengler TJ, Zugck C, Kübler W, Haass M (2002) Do cytokines enable risk stratification to be improved in NYHA functional class III patients? – Comparison with other potential predictors of prognosis. Eur Heart J 23: 70-78

Krüger C, Lahm T, Zugck C, Kell R, Schellberg D, Schweizer MWF, Kübler W, Haass M (2002) Heart rate variability enhances the prognostic value of established parameters in patients with congestive heart failure. Z Kardiol 91: 1003-1012

Zugck C, Haunstetter A, Krüger C, Kell R, Schellberg D, Kübler W, Haass M (2002) Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol 39: 1615-1622

Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, Haass M, Schraeder R, Strasser RH (2004) Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism – Periprocedural safety and mid-term follow-up results of three different occluder systems. Eur Heart J 25: 424-430

Sack FU, Vielfort TJ, Koch A, Haass M, Taylor S, Otto HF, Hagl S, Schnabel PA (2004) The role of platelet derived growth factor in endomyocardial biopsies shortly after heart transplantation in relation to postoperative course. Eur J Cardiothorac Surg 25: 91-97

Jost A, Rauch B, Hochadel M, Winkler R, Schneider S, Jacobs M, Kilkowski C, Kilkowski A, Lorenz H, Muth K, Zugck C, Remppis A, Haass M, Senges J for the HELUMA study group (2005) Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study. Eur Heart J 26: 2689-2697

Jünger J, Schellberg D, Müller-Tasch Th, Raupp G, Zugck C, Haunstetter A, Zipfel S, Herzog W, Haass M (2005) Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail 7: 261-267

Anker SD, Clark AL, Winkler R, Zugck C, Cicoira M, Ponikowski P, Davos CH, Banasiak W, Zardini P, Haass M, Senges J, Coats AJ, Poole-Wilson PA, Pitt B (2006) Statin use and survival in patients with chronic heart failure – results from two observational studies with 5200 patients. Int J Cardiol 112: 234-242

Kreusser MM, Haass M, Buss SJ, Hardt SE, Gerber SH, Kinscherf R, Katus HA, Backs J (2006) Injection of nerve growth factor into stellate ganglia improves norepinephrine reuptake into failing hearts. Hypertension 47: 1-7

Ordonez-Llanos, Santalo-Bel M, Merce-Muntanola J, Collinson PO, Gaze D, Haass M, Katus HA, Chwallek F, Hirschl MM, Derhaschnig U, Müller-Bardorff M, Kellet J, Sylven C, Schulz I, Zerback R for the CARMYT multicentre study. (2006) Risk stratification of chest pain patients by point-of-care cardiac troponin T and myoglobin measured in the emergency department. Clin Chim Acta 365: 93-97

Zugck C, Nelles M, Katus HA, Collinson PO, Gaze DC, Dikkeschei B, Gurr E, Hayen W, Haass M, Hechler C, van Hoof V, Guerti K, van Waes C, Printzen G, Klopprogge K, Schulz I, Zerback R (2006) Multicentre evaluation of new point-of-care test for the determination of NT-proBNP in whole blood. Clin Chem Lab Med 44: 1269-1277

Koch A, Roth W, Steffek TM, Dengler TJ, Haass M, Karck M, Sack FU, Schirmacher P, Schnabel PA (2008) Impact of apoptosis in acute rejection episodes after heart transplantation: immunhistochemical examination of right ventricular myocardial biopsies. Transplant Proc 40: 943-946

Müller-Tasch T, Frankenstein L, Holzapfel N, Schellberg D, Löwe B, Nelles M, Zugck C, Katus H, Rauch B, Haass M, Jünger J, Remppis A, Herzog W (2008) Panic disorders in patients with chronic heart failure. J Psychosom Res 64: 299-303

Holzapfel N, Löwe B, Wild B, Schellberg D, Zugck C, Remppis A, Katus HA, Haass M, Rauch B, Jünger J, Herzog W, Müller-Tasch T (2009) Self-care and depression in patients with chronic heart failure. Heart Lung 2009; 38:392-397

Rosenberg M, Urbansky M, Haass M (2009) Insufficient statin therapy in coronary heart disease is related to the time of the last coronary angiography. J Cardiovasc Pharmacol 53: 215-222

Petrich W, Lewandrowski KB, Muhlestein JB, Hammond ME, Januzzi JL, Lewandrowski EL, Pearson RR, Dolenko B, Früh J, Haass M, Hirsch MM, Köhler W, Mischler R, Möcks J, Ordonez-Llanos J, Quarder O, Somorjai R, Staib A, Sylven C, Werner G, Zerback R (2009) Potential of mid-infrared spectroscopy to aid the triage of patients with acute chest pain. Analyst 134: 1092-1098

Kristen AV, Schumacher B, Strych K, Lossnitzer D, Friederich H-C, Hilbel T, Haass M, Katus HA, Schneider A, Streitberger KM, Backs J (2010) Acupuncture improves exercise tolerance of heart failure patients – a placebo-controlled study. Heart 96: 1396-1400

O´Connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, Carson P, Haass M, Hauptman PJ, Metra M, Oren RM, Patten R, Pina I, Roth S, Sackner-Bernstein JD, Traver B, Cook T, Gheorhghiade M (2010) Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J 159: 841-849

Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, Lopez-Sendon J, Teerlink JR, White M, McMurray JJ, Komajda M, McKelvie R, Ptaszynska A, Hetzel SJ, Massie B, Carson PE (2010) Mode of death in patinets with heart failure and a preserved ejection fraction: results from Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-Preserve) Trial. Circulation 121: 1395-1405

Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM. Carson PE (2011) Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the I-PRESERVE trial. Circ Heart Fail: epub 24. Februar 2011

Übersichtsarbeiten und Buchbeiträge

Haass M (2005) Biomarker bei Herzinsuffizienz. Kardiologie up2date 1: 23-44

Haass M (2005) Kardiale Marker bei Herzinsuffizienz. In: Haass M, Katus HA (Hrsg) Diagnostische Marker in der Kardiologie. Uni-Med Verlag, Bremen. pp 13-31

Rosenberg M, Haass M (2005) Leitlinien der Lipdtherapie – Umsetzung in den Praxisalltag. Internist 46 (Suppl. 1): S11-S17

Zugck C, Remppis A, Katus HA, Rauch B, Haass M (2006) Ansätze zur Behandlung der chronischen Herzinsuffizienz. Kardiologie up2date 2: 51-70

Haass M, Müller-Tasch T, Jünger J (2007) Depression bei chronischer Herzinsuffizienz: Kardiologie up2date 3: 7-12

Haass M, Hasslacher C, Krüger C (2008) Diabetes mellitus und Herzinsuffizienz. Kardiologie up2date 4: 31-45

Regitz-Zagrosek V, Gohlke-Bärwoöf C, Geibel-Zehender A, Haass M, Kämmerer H, Kruck I, Nienaber C (2008) Heart disease in pregnancy. Clin Res Cardiol 97: 630-665

Haass M (2009) Vaptane und Herzinsuffizienz. Ther Umsch 66: 735-40

Haass M, Radzewitz A, Walter S, Miche E (2010) Besonderheiten bei der Behandlung der chronischen Herzinsuffizienz im Alter. Kardiologie up2date 6: 11-18

Haass M, Zugck C, Rauch B (2010) Die Behandlung der chronischen Herzinsuffizienz – heute. Arzneiverordnung in der Praxis 37: 98-101

Haass M (2011) Highlights of the latest clinical trials from the 2010 Scientific Sessions of the American Heart Association. Future Cardiol 7: Im Druck

Haass M, Giannitsis E, Katus HA (Herausgeber) (2011) Diagnostische Marker in der Kardiologie. 2. Auflage. UNI-MED Verlag, Bremen

Haass M, Hechler C (2011) Tolvaptan. Internistische Praxis: Im Druck

Haass M, Walter S, Zugck S (2011) Telemonitoring bei chronischer Herzinsuffizienz: TELE-HF und TIM-HF. Kardiologie up2date 7: Im Druck